The Cool Down on MSN

Amgen recalls nearly 1 million U.S. bottles of heart drug Corlanor over possible contamination

Tests found that the foreign matter does not pose a clinical risk to patients.
The Cool Down on MSN

Nearly 1 million bottles of heart, kidney medications recalled nationwide over 'foreign substance'

"Cause temporary or medically reversible adverse health consequences." ...
Becker's Hospital Review

Amgen recalls 934K+ bottles of heart, kidney drugs

Amgen recalls 934K bottles of Corlanor and Sensipar due to foreign material and manufacturing deviations, per FDA June 23 report.

900,000 Bottles of Heart and Kidney Medications Recalled For 'Unexpected Foreign Matter' in Bottles

The tablets involved in the recall were distributed in the U.S. from Oct. 28, 2021, to Dec. 30, 2025 ...
Becker's Hospital Review

Amgen declines FDA request to withdraw rare disease drug

Amgen has declined a request from the FDA to voluntarily withdraw Tavneos from the U.S. market. The FDA on Jan. 16 cited concerns about ChemoCentryx’s process for re-adjudicating primary endpoint ...
The Financial

Amgen’s Vectibix boosts survival in colorectal cancer patients

The FINANCIAL — Amgen on June 18 announced that a Phase 3 study evaluating Vectibix (panitumumab) and best supportive care (BSC) met its primary endpoint, demonstrating a statistically significant ...
The Financial

Amgen Submits Supplemental Biologics License Application For Prolia

The FINANCIAL — Amgen on July 31 announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Prolia (denosumab) for the treatment ...